Genezen
- Website
- genezen.com
- Total Funding
- $18.5M
- Last Round
- $18.5M Growth EquityNov 2023
- Rounds
- 2
About
Genezen is a Biotech company. It has raised $18.5M in total across 2 rounds, most recently a $18.5M Growth Equity round in Nov 2023. Investors include Ampersand Capital Partners.
Funding History
Nov 2023
Sign up to see all 2 rounds
Growth Equity — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
Therapeutics company working in drug discovery and development using fungi with genomics approach...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/genezen"><img src="https://indexed.vc/api/badge/company/genezen" alt="Genezen on Indexed.vc" width="260" height="76" /></a>